Supplementary Data from Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Authors :: Paul M. Sondel
Julie R. Park
Rochelle Bagatell
John M. Maris
Susan L. Cohn
Katherine K. Matthay
Marguerite Parisi
Barry L. Shulkin
Malcolm Smith
Sheena C. Tenney
Wendy B. London
Ayse Batova
Jacquelyn A. Hank
Jacek Gan
Mitchell B. Diccianni
Arlene Naranjo
M. Fevzi Ozkaynak
Andrew L. Gilman
Alice L. Yu
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Figure S1a

Full Text Access

Tools